PMN Press Releases

Article content The company to showcase exponential throughput and economic gains with its comprehensive 3D printer portfolio spanning from desktop...

Article content Zanidatamab zovodotin shown to have manageable safety profile with encouraging, single-agent anti-tumor activity in patients with HER2+ cancers...